Skip to main content

Advertisement

Log in

Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B (2009) Placebo controlled-trial of rituximab in IgM anti-MAG antibody demyelinating neuropathy. Ann Neurol; 65(3):286–293

    Article  PubMed  CAS  Google Scholar 

  2. Joint Task Force of the EFNS and the PNS (2010) Guideline on management of paraproteinemic demyelinating neuropathies Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. J Peripher Nerv Syst 15(3):185–195

    Article  Google Scholar 

  3. Graham RC, Hughes RA (2006) A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77:973–976

    Article  PubMed  CAS  Google Scholar 

  4. Merkies IS, Schmitz PI, van de Meche FG, van Doorn PA (2002) Psychometric evaluation of new sensory scale in immune mediated polyneuropathies. Neurology 54:943–949

    Google Scholar 

  5. Delmont E, Benaïm C, Launay M, Sacconi S, Soriani MH, Desnuelle C (2009) Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? J Neurol 256(11):1876–1880

    Article  PubMed  Google Scholar 

  6. Latov N, Renaud S (2004) Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies. J Neurol Sci 220:127–129

    Article  PubMed  Google Scholar 

  7. Renaud S, Gregor M, Fuhr P, Lorenz D, Deuschl G, Gratwohl A, Steck AJ (2003) Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27(5):611–615

    Article  PubMed  CAS  Google Scholar 

  8. Renaud S, Fuhr P, Gregor M, Schweikert K, Lorenz D, Daniels C, Deuschl G, Gratwohl A, Steck AJ (2006) High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology 66(5):742–744

    Article  PubMed  CAS  Google Scholar 

  9. Benedetti L, Briani C, Grandis M, Vigo T, Gobbi M, Ghiglione E, Carpo M, Cocito D, Caporale CM, Sormani MP, Mancardi GL, Nobile-Orazio E, Schenone A (2007) Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J Peripher Nerv Syst 12(2):102–107

    Article  PubMed  CAS  Google Scholar 

  10. Niermeijer JM, Eurelings M, Lokhorst HL, van der Pol WL, Franssen H, Wokke JH, Notermans NC (2009) Rituximab for polyneuropathy with IgM monoclonal gammopathy. J Neurol Neurosurg Psychiatry 80(9):1036–1039

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emilien Delmont.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delmont, E., Jeandel, P.Y., Benaïm, C. et al. Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies. J Neurol 258, 1717–1719 (2011). https://doi.org/10.1007/s00415-011-5994-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-5994-0

Keywords

Navigation